GSK press releases Follow Trelegy Ellipta approved in China for use in adults with uncontrolled asthma Asthma indication introduces an important option for patients with uncontrolled symptoms https://www.gsk.com/en-gb/media/press-releases/trelegy-ellipta-approved-in-china/ gsk.com
